Background/Aims: Obesity is an epidemic and its prevelance and number of patients underwent bariatric surgery continue to increase worldwide. This study aimed to evaluate endoscopic findings and co-morbidities, to investigate the prevelance of Helicobacter pylori (H. pylori) infection and the relationship between body mass index (BMI) and gastroesophageal sphincter incompetency in obese patients. Materials and Methods: An upper gastrointestinal system endoscopy and mucosal sampling were performed in all patients hospitalized for bariatric surgery. Age, gender, BMI, co-morbidities and endoscopic findings were recorded. Gastroesophageal sphincter incompetency was classified according to Hill classification. The patients were divided into two groups: group I, endoscopically normal and group II, endoscopically abnormal. Results: Total 127 patients were enrolled into prospective study. Of these, 93 (%73.2) were female and the mean age was 38.9±12.5 years (range: 16-68). Abnormal endoscopic findings and H. pylori were detected in 80.4% and 44.9% of patients, respectively. In group II, patients were older, BMI higher and H. pylori more prevalent (all statistically significant). Diabetes mellitus, hypertension and dyslipidemia were the most frequent common co-morbidities. Rate of multiple co-morbidities were more common in group II. Gastroesophageal sphincter incompetency in total group was observed in a rate of 46.5% and was weakly correlated with BMI. Conclusion: Four-fifths of obese patients have at least one endoscopic abnormal finding, three fourth at least one co-morbidity and half H. pylori positivity. Upper gastrointestinal system endoscopy should be performed routinely in all patients to predict and prevent complications following bariatric surgery.
INTRODUCTION
Obesity is an epidemic with an increasing prevalence worldwide. According to World Health Organization estimation, there are over 500 million obese adults [BMI (body mass index)>30 kg/m 2 ] across the world (1). Obesity is known to increase susceptibility to several conditions including type 2 diabetes mellitus (DM), hypertension (HTN), dyslipidemia, coronary artery disease, some cancers, sleep apnea syndrome, gastroesophageal reflux disease (GERD) and esophageal motility disorders (2, 3) . Initial treatment of obesity includes diet, life-style changes, exercise and some medicines, but given the long-term outcomes, effective treatment appears to be achieved by bariatric surgery (4) . Body weight reductions along with improvements in obesity related co-morbidities are achieved following bariatric surgery (5) . Endoscopy is recommended as a routine practice in all patients to identify and treat endoscopic abnormalities and H. pylori positivity prior to bariatric surgery (6) . A high prevelance of lower esophageal sphincter (LES) incompetency and hiatal hernia secondary to increased intraabdominal pressure frequently leads to GERD symptoms in obese persons (7) . Despite the many studies in the lit-erature, the relationship between obesity and gastroesophageal sphincter incompetency (GSI) and H. pylori infection has not been fully clarified (7) (8) (9) (10) .
The purpose of the present study is to evaluate endoscopic findings and co-morbidities, to investigate the prevelance of H. pylori infection and the relationship between BMI and GSI, and to compare endoscopically normal and abnormal groups in terms of several parameters.
MATERIALS AND METHODS
The current prospective study was approved by the institutional review board (BAV. 71306642-050.01.04-811) and conducted between June 2010 and February 2014. The study was carried out according to ethical principles for medical research involving human subjects outlined in the Helsinki Declaration. Written informed consent was obtained from all patients. The study included 127 patients who presented to our University Hospital for obesity surgery. The patients' demographics, BMI and co-morbidities (DM, HTN, sleep apnea syndrome, congestive heart failure, ischemic heart disease, hypothyroidism, dyslipidemia, chronic obstructive pulmonary disease, asthma and chronic renal failure) were recorded. All patients underwent upper gastrointestinal system endoscopy prior to obesity surgery. Endoscopic interventions were performed by two gastroenterologists (A.D. and B.B.) with relevant experience using the PENTAX EG-290-Kp videogastroscope (Pentax, Tokyo, Japan). Endoscopy was extended up to the second duodenal portion in all patients and all endoscopic data were recorded. The diagnosis of esophagitis was based on the criteria described in Los Angeles Classification (11) . In addition, we carefully examined the structure of gastroesophageal junction to assess the GSI, using a retroflexed view during gastric inflation. The GSI was graded from I to IV according to the Hill classification (12,13) ( Table 1 ). In fact, although gastritis is a histopathologic diagnosis, existence of mucosal erosions, hyperemia and edema were considered as endoscopic gastritis. Whether the patients were positive for H. pylori was investigated systematically by obtaining two mucosal samples each from antrum and corpus. Histopathological analysis was performed by a pathologist (N.Ü.) specialized in the gastrointestinal tract using Giemsa stain. The patients were divided to into normal (group I) and abnormal group (group II) in terms of existence of at least one abnormal endoscopic finding.
Statistical analysis
SPSS for Windows 19.0 (SPSS, Chicago, IL, USA) was used for statistical analyses. Suitability of parameters to normal distribution was assessed with Kolmogorov-Smirnov test. Descriptive statistical methods (mean, standard deviation and percentage) as well as Student's t test for inter-group comparisons of normally distributed data and Mann-Whitney U test for intergroup comparisons of non-normally distributed quantitative data were used for the evaluation of the study data. Chi-square test and Fisher's exact tests were used to compare qualitative data. Pearson correlation coefficient was used to determine the correlation between variables (BMI and GSI grading). The results were evaluated using hazard ratio and 95% confidence interval. In these analyses, p<0.05 was considered statistically significant.
RESULTS
Of the 127 patients, 93 (73.2%) were females and mean age was 38.9±12.5 years (range 16-68). Mean BMI was 48±8.08 (range 35-80). Of the patients, 25 (19.6%) were endoscopically normal (group I) and 102 (80.4%) were abnormal (group II).
Endoscopic abnormalities
Most common endoscopic finding was endoscopic gastritis (64.6%). Endoscopic abnormalities are summarized in Table 2 .
Co-morbidity
Of the 127 patients, 43 (33.9%) had no co-morbidity, while 84 (66.1%) had at least one co-morbidity. In 27 (21.3%) patient three and more co-morbidities were documented (Table 3) . Despite multiple co-morbidities were more common in group II, no statistically significant difference was observed between two groups (p<0.05).
Helicobacter Pylori H. pylori was positive in 57 (44.9%) patients.
Comparison of both groups
Rate of H. pylori positivity, mean age and mean BMI were significantly higher in the group II (Table 4) .
The prominent fold of tissue along the lesser curvature apposed closely to the endoscope.
Grade II
The fold was present but less well defined than in grade I, and some periods of opening and rapid closing around the endoscope were found Grade III The fold was not prominent and often failed to close around the endoscope, gripping it tightly.
Grade IV There was no fold and the lumen of the esophagus was open. The squamous epithelium of the esophagus could be seen below (17) but was 44.9% in morbid obese patients in our study, which was lower compared to the overall Turkish population. H. pylori prevalence in obese individuals is still disputable, reported from different studies to range from 8.7 to 85.5% (10) . H. pylori prevalence was lower in obese groups compared to control groups in all studies but the exact cause is unknown (10, 18) . Additionally, we found that H. pylori prevalence was increased in patients with higher BMIs and endoscopic abnormalities. Interestingly, Kamada et al. (19) studied a H. pylori-positive Japanese population and demonstrated significant weight increase in patients who received H. pylori eradication therapy compared to those who did not. Animal studies have shown that leptin levels increased, ghrelin levels decreased, weight gain was prevented, glucose tolerance improved and fasting plasma glucose levels decreased in the presence of H. pylori colonization (10, 18) . While genetic modification is an important predisposing factor for obesity, it is acknowledged that human genome has not changed significantly over the last century. Excessive calorie intake and sedentary life style are major risk factors for obesity and DM but these do not explain the worldwide obesity epidemiology. According to a recent hypothesis, the leading factors for obesity are environmental chemicals, stress, immunologic changes, micronutrient deficit and intestinal microbiota (20) . In our series, co-morbidity was also common among obese patients and a significant relationship was demonstrated between number of co-morbidities and endoscopic abnormalities.
The significant relationship between GERD and obesity and higher GERD prevalence with increasing BMIs have also been 
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Turk J Gastroenterol 2015; 26: described in the literature (21) . The causes of this are believed to be increased intraabdominal pressure, deficiency of the lower esophageal sphincter, increased prevelance of hiatal hernia, impaired esophageal motility due to abnormal visceral stimulation and bile and pancreatic enzyme reflux due to vagal abnormalities (21, 22) . Herbella et al. (9) reported increased LES pressure in obese persons, but Ayazi et al. (7) demonstrated that LES pressure is less pronounced in obese individuals and that LES defects increase with higher BMIs. In our study, GSI grading was weakly correlated with BMI.
In conclusion, four-fifths of obese patients have at least one endoscopic abnormal finding, three-fourths have at least one comorbidity, and half have H. pylori-positivity. H. pylori frequency in obese patients is lower in comparison with general population, but more prominent in the obese patients with abnormal endoscopic findings. Therefore, upper gastrointestinal system endoscopy should be performed routinely in all patients to predict and prevent complications following bariatric surgery. Eradication of H. pylori in obese patients can be useful to prevent H. pylori related complications.
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